|Former Common name||calmegin-cre|
|H-2 Haplotype||No Data|
|Background strain||No Data|
|Strain development||Developed by Masato Ikawa, Osaka University in 1997.|
|Strain description||This transgenic mouse expresses the cre-recombinase under the control of the calmegin gene promoter. This strain can be used to make an inducible knock-out by crossing with the other genetically-engineered mice that have floxed genes.|
|Colony maintenance||Carrier x Noncarrier [C57BL/6NCrSlc]|
|Promoter||mouse calmegin promoter|
|Symbol name||Phage P1 Cre recombinase|
|Common name||No Data|
|Symbol description||No Data|
|References||Biochem Biophys Res Commun. 2004 Aug 20;321(2):275-9.
Lineage-specific cell disruption in living mice by Cre-mediated expression of diphtheria toxin A chain.
|Research applications||Cre/loxP system,
Reproductive Biology Research
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
Biochem. Biophys. Res. Commun., 321, 275-279 (2004).
RECIPIENT which wants to use the BIOLOGICAL RESOURCE for the purpose other than education or not-for-profit research is requested to enter into a Material Transfer Agreement with Osaka University (http://www.uic.osaka-u.ac.jp/en/index.html). The RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the BIOLOGICAL RESOURCES. The RECIPIENT which wants to use the BIOLOGICAL RESOURCE even after five years must obtain a written consent from the DEPOSITOR again.
|2||Genotyping protocol <PCR>|
|Depositor||Okabe, Masaru (Osaka university)|
|Strain Status /